(MENAFN – AETOSWire) (BUSINESS WIRE )–Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new data regarding the use of Nemluvio for atopic dermatitis and prurigo. ..
(MENAFN – AETOSWire) (BUSINESS WIRE )–Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new data regarding the use of Nemluvio for atopic dermatitis and prurigo. ..